Teza Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $180K | Sell |
10,122
-986
| -9% | -$17.6K | 0.13% | 284 |
|
|
2025
Q1 | $198K | Sell |
11,108
-89,092
| -89% | -$1.59M | 0.09% | 371 |
|
|
2024
Q4 | $2.99M | Buy |
100,200
+85,312
| +573% | +$2.54M | 0.45% | 44 |
|
|
2024
Q3 | $233K | Sell |
14,888
-10,886
| -42% | -$170K | 0.03% | 523 |
|
|
2024
Q2 | $442K | Sell |
25,774
-446
| -2% | -$7.64K | 0.05% | 381 |
|
|
2024
Q1 | $410K | Buy |
26,220
+14,792
| +129% | +$231K | 0.05% | 380 |
|
|
2023
Q4 | $171K | Sell |
11,428
-407
| -3% | -$6.08K | 0.03% | 506 |
|
|
2023
Q3 | $191K | Buy |
+11,835
| New | +$191K | 0.03% | 539 |
|
|
2023
Q1 | – | Sell |
-3,609
| Closed | -$265K | – | 652 |
|
|
2022
Q4 | $265K | Buy |
+3,609
| New | +$265K | 0.05% | 476 |
|
|
2021
Q3 | – | Sell |
-992
| Closed | -$220K | – | 523 |
|
|
2021
Q2 | $220K | Buy |
+992
| New | +$220K | 0.04% | 510 |
|